Infinity Pharmaceuticals

Infinity Pharmaceuticals Minority Interest

Minority Interest (Non-Controlling Interest) of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026.

Minority Interest

-USD

Last updated:

Minority Interest (Non-Controlling Interest) of Infinity Pharmaceuticals is 2026 - USD. Minority Interest (Non-Controlling Interest) of Infinity Pharmaceuticals was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

On Eulerpool you can find the complete historical development of Minority Interest (Non-Controlling Interest) Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Minority interest represents the portion of subsidiaries not owned by the parent company. It reflects third-party ownership stakes in consolidated entities.

Minority Interest (Non-Controlling Interest)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Minority Interest (Non-Controlling Interest)'s Infinity Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals